177 related articles for article (PubMed ID: 22241164)
1. P50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatment.
Oranje B; Aggernaes B; Rasmussen H; Ebdrup BH; Glenthøj BY
Schizophr Bull; 2013 Mar; 39(2):472-80. PubMed ID: 22241164
[TBL] [Abstract][Full Text] [Related]
2. Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months' treatment with quetiapine.
Aggernaes B; Glenthoj BY; Ebdrup BH; Rasmussen H; Lublin H; Oranje B
Int J Neuropsychopharmacol; 2010 Nov; 13(10):1383-95. PubMed ID: 20633319
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of adenosine A2A receptors induced by atypical antipsychotics and its correlation with sensory gating in schizophrenia patients.
Zhang J; Abdallah CG; Wang J; Wan X; Liang C; Jiang L; Liu Y; Huang H; Hong X; Huang Q; Wu R; Xu C
Psychiatry Res; 2012 Dec; 200(2-3):126-32. PubMed ID: 22705363
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.
Hong X; Chan RC; Zhuang X; Jiang T; Wan X; Wang J; Xiao B; Zhou H; Jiang L; Weng B
Schizophr Res; 2009 Mar; 108(1-3):151-7. PubMed ID: 19106034
[TBL] [Abstract][Full Text] [Related]
5. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.
Adler LE; Olincy A; Cawthra EM; McRae KA; Harris JG; Nagamoto HT; Waldo MC; Hall MH; Bowles A; Woodward L; Ross RG; Freedman R
Am J Psychiatry; 2004 Oct; 161(10):1822-8. PubMed ID: 15465979
[TBL] [Abstract][Full Text] [Related]
6. P50 gating at acute and post-acute phases of first-episode schizophrenia.
Devrim-Uçok M; Keskin-Ergen HY; Uçok A
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1952-6. PubMed ID: 18929611
[TBL] [Abstract][Full Text] [Related]
7. Prepulse inhibition of the startle reflex in schizophrenia remains stable with short-term quetiapine.
Molina V; López DE; Villa R; Pérez J; Martín C; Ballesteros A; Cardoso A; Sancho C
Eur Psychiatry; 2011; 26(5):271-5. PubMed ID: 20542668
[TBL] [Abstract][Full Text] [Related]
8. Selective attention and mismatch negativity in antipsychotic-naïve, first-episode schizophrenia patients before and after 6 months of antipsychotic monotherapy.
Oranje B; Aggernaes B; Rasmussen H; Ebdrup BH; Glenthøj BY
Psychol Med; 2017 Sep; 47(12):2155-2165. PubMed ID: 28443529
[TBL] [Abstract][Full Text] [Related]
9. Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients.
Boutros NN; Brockhaus-Dumke A; Gjini K; Vedeniapin A; Elfakhani M; Burroughs S; Keshavan M
Schizophr Res; 2009 Sep; 113(2-3):339-46. PubMed ID: 19524407
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic effects on auditory sensory gating in schizophrenia patients.
Sánchez-Morla EM; Santos JL; Aparicio A; García-Jiménez MA; Villanueva C; Martínez-Vizcaíno V; Arango C
Eur Neuropsychopharmacol; 2009 Dec; 19(12):905-9. PubMed ID: 19833483
[TBL] [Abstract][Full Text] [Related]
11. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications.
Light GA; Geyer MA; Clementz BA; Cadenhead KS; Braff DL
Am J Psychiatry; 2000 May; 157(5):767-71. PubMed ID: 10784470
[TBL] [Abstract][Full Text] [Related]
12. P50 gating in deficit and nondeficit schizophrenia.
Santos JL; Sánchez-Morla EM; Aparicio A; García-Jiménez MA; Villanueva C; Martínez-Vizcaíno V; Arango C
Schizophr Res; 2010 Jun; 119(1-3):183-90. PubMed ID: 20153607
[TBL] [Abstract][Full Text] [Related]
13. Auditory and visual P300 reflecting cognitive improvement in patients with schizophrenia with quetiapine: a pilot study.
Park EJ; Han SI; Jeon YW
Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):674-80. PubMed ID: 20304022
[TBL] [Abstract][Full Text] [Related]
14. Baseline dependency of nicotine's sensory gating actions: similarities and differences in low, medium and high P50 suppressors.
Knott V; de la Salle S; Smith D; Phillipe T; Dort H; Choueiry J; Impey D
J Psychopharmacol; 2013 Sep; 27(9):790-800. PubMed ID: 23744798
[TBL] [Abstract][Full Text] [Related]
15. Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients.
Düring S; Glenthøj BY; Andersen GS; Oranje B
Neuropsychopharmacology; 2014 Dec; 39(13):3000-8. PubMed ID: 24954063
[TBL] [Abstract][Full Text] [Related]
16. P50 suppression deficits and psychopathology in Han Chinese patients with schizophrenia.
Zhu XL; Tan SP; Wang ZR; Zhang JG; Li D; Fan FM; Zhao YL; Zou YZ; Tan YL; Yang F; Zhang XY
Neurosci Lett; 2017 Jul; 653():346-350. PubMed ID: 28606770
[TBL] [Abstract][Full Text] [Related]
17. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients.
Brockhaus-Dumke A; Schultze-Lutter F; Mueller R; Tendolkar I; Bechdolf A; Pukrop R; Klosterkoetter J; Ruhrmann S
Biol Psychiatry; 2008 Sep; 64(5):376-84. PubMed ID: 18395700
[TBL] [Abstract][Full Text] [Related]
18. Sensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia.
Hazlett EA; Rothstein EG; Ferreira R; Silverman JM; Siever LJ; Olincy A
Schizophr Res; 2015 Feb; 161(2-3):283-90. PubMed ID: 25482574
[TBL] [Abstract][Full Text] [Related]
19. Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms.
Ebdrup BH; Skimminge A; Rasmussen H; Aggernaes B; Oranje B; Lublin H; Baaré W; Glenthøj B
Int J Neuropsychopharmacol; 2011 Feb; 14(1):69-82. PubMed ID: 20701823
[TBL] [Abstract][Full Text] [Related]
20. Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia.
Zhang XY; Liu L; Liu S; Hong X; Chen DC; Xiu MH; Yang FD; Zhang Z; Zhang X; Kosten TA; Kosten TR
Am J Psychiatry; 2012 Sep; 169(9):974-81. PubMed ID: 22952075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
